Revertants of mouse cells transformed by murine sarcoma virus. II. Flat variants induced by fluordeoxyuridine and colcemid.
D000372:Agglutination Tests; D000818:Animals; D000956:Antigens, Viral / Q000032:analysis; D002459:Cell Fusion; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D002478:Cells, Cultured / Q000187:drug effects* / Q000201:enzymology / Q000276:immunology; D003078:Colchicine / Q000494:pharmacology*; D003208:Concanavalin A; D003673:Defective Viruses / Q000254:growth & development; D004305:Dose-Response Relationship, Drug; D005467:Floxuridine / Q000494:pharmacology*; D017988:Gammaretrovirus / Q000254:growth & development*; D014644:Genetic Variation; D006378:Helper Viruses / Q000254:growth & development; D009052:Leukemia Virus, Murine / Q000276:immunology; D051379:Mice; D008979:Moloney murine leukemia virus / Q000254:growth & development; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism; D051381:Rats; D013942:Thymine Nucleotides / Q000378:metabolism; D014316:Tritium; D014762:Viral Interference; D014779:Virus Replication
D000956:Antigens, Viral; D013942:Thymine Nucleotides; D005467:Floxuridine; D014316:Tritium; D003208:Concanavalin A; D012194:RNA-Directed DNA Polymerase; D003078:Colchicine